Vendor PresentationsSunday, February 20 — 12:00 pm – 1:30 pmAlyssum Room, Level 3Exhibit Booth: 214Moving Beyond ProteomicsSpeaker: Detlev Suckau, Bruker Daltonik GmbHIn current proteomics studies as well as biopharmaceutical developmentand characterization, post-translational modificationsobtain increasing attention. Amongst these, glycosylation isprominent but the lack <strong>of</strong> bioinformatics solutions slowed downthe analysis <strong>of</strong> glycoproteins in both, the biopharmaceutical industryas well as in proteomics studies.In this seminar, we introduce new solutions that include a newglycoprotein and glycoproteomics enabling bioinformatics platformand show examples from selected glycoprotein characterizationsincluding glycan and direct glycopeptide analysis usingBrukers leading ESI-MSn and MALDI platforms.Dedicated solutions for the development and quality control <strong>of</strong>Biologicals and Biosimilars will be described that show you howto rapidly characterize therapeutic proteins with the confidencethat is derived from the high specificity <strong>of</strong> Brukers ultra-highresolution QTOF maXis.As a further extension <strong>of</strong> classical protein characterization andvalidation workflows, we describe recent advances in Top-Downprotein characterization tools that will make your C- and N-terminaldefinitions specific and rapid. The ESI-ETD and MALDITop-Down Sequencing approaches will also forward your proteomicsresearch as they provide simultaneous access to PTManalysis, protein is<strong>of</strong>orm differentiation and proteolytic regulationevents that are not addressed with current technologies.Grand Oaks Ballroom,Rooms N&O, Level 2Exhibit Booth: 71412:00 pm – 12:30 pmAdvances in Sample Preparation <strong>of</strong> LowAbundant Proteins using Magnetic BeadsSpeaker: Helena Hedlund, Global Product Manager, GEHealthcare Life SciencesLow abundant proteins are <strong>of</strong>ten biologically important butdifficult to detect. Some proteins are present in a few copieswhereas others have a short transient presence. To be able toincrease the detection and identification rate, efficient samplepreparation methods are necessary. We have combined establishedaffinity chromatography methods with magnetic beadtechnology for the enrichment <strong>of</strong> such challenging proteins. Inthe first study changes in tyrosine phoshorylation in cancer cellsupon drug treatment was investigated. Immmonoprecipitationusing Protein G Mag Sepharose TM was used for enrichment <strong>of</strong>phosphorylated proteins prior to a 2-D DIGE experiment. Theeffect <strong>of</strong> the treatment will be presented as well as protein identificationfrom MS analysis.In the second study screening for optimal purification conditionsfor a number <strong>of</strong> integral membrane proteins was performed. Vitalparameters as choice <strong>of</strong> detergent wash and elution bufferconcentrations were evaluated. All experiments were done usingNi2+-charged His Mag Sepharose Ni. Results from screeningfor several detergents gave reliable results that could be fed int<strong>of</strong>urther scale-up experiments. The magnetic bead format simplifiedand shortened the handling procedures through-out thesetwo different workflows.Vendor Presentations12:30 pm – 1:00 pmQuantitative Western Blotting withAmersham TM ECL TM PrimeSpeaker: Maria Winkvist, Scientist, GE Healthcare LifeSciencesWestern blotting is a well established technique in life scienceresearch. Traditionally the technique has been restricted toqualitative protein analysis. However, development <strong>of</strong> refineddetection methods and reagents has opened up the possibilityto use the technique in quantitative analysis, for accurate monitoring<strong>of</strong> small changes in protein abundance and for detection<strong>of</strong> posttranslational modifications.120 • <strong>ABRF</strong> <strong>2011</strong> — Technologies to Enable Personalized Medicine
This workshop will present ways to achieve quantitative Westernblotting by optimizing the imaging system and detection reagent.The impact <strong>of</strong> normalization, signal-to-noise, backgroundnoise and other experimental factors will also be discussed.1:00 pm – 1:30 pm2-D DIGE Analysis <strong>of</strong> Multicellular TumorSpheroids in Evaluation <strong>of</strong> Breast CancerTreatmentSpeaker: Viola Ruddat, Ph.D., Senior Applications Scientist,GE Healthcare Life SciencesMany cancers can be diagnosed using Positron Emission Tomography(PET) to visualize tumors. PET can also be used to monitorhow effective various treatments are in individual patientsby observing the decrease in tumor tissue. Tumor spheroids arecancer cells grown on agar coated dishes forming a 3D structure.They are widely used in preclinical cancer research, where themulticellular tumor spheroid model is considered biologicallyand physiologically similar to in vivo grown tumors.Grand Oaks Ballroom,Rooms P&Q, Level 2Exhibit Booth: 515Illumina’s New <strong>2011</strong> Portfolio andAnnouncementsIllumina’s broad portfolio <strong>of</strong> sequencing and array solutionsempowers scientists in labs <strong>of</strong> all sizes to take their researchfurther, faster. Please join us to hear the details about the recentannouncements <strong>of</strong> the terabase sequencing milestone, ourability to enable our customers to reach 600 Gb/run this spring,and our newest Platform, MiSeq.We’ll also describe our progressive research path for GWAS,our sequencing service without compromise and Eco, our ultraaccessibleqPCR system.In this workshop, we will present how we have used Two-dimensionalDifference Gel Electrophoresis (2-D DIGE) analysis to gainmore insight in changes <strong>of</strong> protein expression as a result <strong>of</strong> drugtreatment <strong>of</strong> multicellular tumor spheroids.Monday, February 21 — 12:00 pm – 1:30 pmGrand Oaks Ballroom,Rooms R&S, Level 2Exhibit Booth: 616Advanced Technologies for AntibodyDiscovery and Cell ScreeningSpeakers: Mark Truesdale, Gabe Longoria and AlisonGlaserThe use <strong>of</strong> antibodies in investigating and treating diseases isuniversal, however traditional methods for antibody developmentare time consuming and costly. The Genetix ClonePix TM FLsystem improves operational efficiency by reducing timelines,minimizing resource requirement and allows higher throughput<strong>of</strong> projects.Understanding disease mechanisms through the culture andstudy <strong>of</strong> relevant cell lines requires multiple technologies. Imagingsystems from Genetix are used to characterize cell growthand quantify the responses <strong>of</strong> cells to different treatments. Forrapid determination <strong>of</strong> cell growth in microwell plates, Clone-Select Imager TM provides objective, quantitative and consistentcharacterization <strong>of</strong> cell growth prior to investigation <strong>of</strong> cellularresponses to different treatments such as siRNA, small moleculeor antibody. To determine the responses <strong>of</strong> cells, CellReporterTM is used for fluorescent cell- and bead-based assays. Intuitiveworkflows provide flexibility to optimize and standardize assaysfrom image acquisition through to data analysis. Typical applicationsinclude cell-based assays for cell cycle analysis, apoptosisor monitoring protein translocation and bead-based homogeneousassays for quantifying cellular protein production.This seminar will present the latest technologies and applicationsfor screening cells, identification and isolation <strong>of</strong> clones,and data-rich cell based assays.Vendor Presentations<strong>ABRF</strong> <strong>2011</strong> — Technologies to Enable Personalized Medicine • 121
- Page 7 and 8:
Meeting SponsorsThe Association of
- Page 9 and 10:
Registration ServicesRegistration S
- Page 12 and 13:
Presenter InformationPresenter Info
- Page 14 and 15:
AwardsABRF Annual Award for Outstan
- Page 16 and 17:
ABRF Robert A. Welch Outstanding Re
- Page 18 and 19:
Program-at-a-GlanceProgram-at-a-Gla
- Page 20 and 21:
Sunday, February 20 (Continued)(S1-
- Page 22 and 23:
Sunday, February 20 (Continued)(W3-
- Page 24 and 25:
Monday, February 21 (Continued)12:0
- Page 26 and 27:
Tuesday, February 22 (Continued)9:0
- Page 28 and 29:
Tuesday, February 22 (Continued)(W1
- Page 30 and 31:
Satellite Educational Workshop Spon
- Page 32 and 33:
SW2: An Introduction to Metabolomic
- Page 34 and 35:
SW4: Lean Management in Core Facili
- Page 36 and 37:
Plenary Session AbstractsPlenary Se
- Page 38 and 39:
Scientific Session AbstractsScienti
- Page 40 and 41:
Scientific SessionAbstractsstatisti
- Page 42 and 43:
Scientific SessionAbstracts(S5) Hig
- Page 44 and 45:
Scientific SessionAbstracts(S7-2) S
- Page 46 and 47:
Workshop Session AbstractsWorkshop
- Page 48 and 49:
Workshop SessionAbstractscase incor
- Page 50 and 51:
Workshop SessionAbstracts(W7) Cellu
- Page 52 and 53:
Workshop SessionAbstractsresolution
- Page 54 and 55:
(W14-3) Galaxy Next Generation Sequ
- Page 56 and 57:
Research Group Presentation Abstrac
- Page 58 and 59:
Research GroupPresentation Abstract
- Page 60 and 61:
Research GroupPresentation Abstract
- Page 62 and 63:
Poster Session Abstracts**ABRF Post
- Page 64 and 65:
Poster Abstractsglobal gene express
- Page 66 and 67:
Poster Abstractsdiscussions of cont
- Page 68 and 69:
Poster Abstractspossible applicatio
- Page 70 and 71:
Poster Abstracts129 Bravo Automated
- Page 73 and 74: distribution. Additionally, we show
- Page 75 and 76: Illumina Genome Analyzer. PicoPlex
- Page 77 and 78: uniformity, reproducibility of enri
- Page 79 and 80: kits for Tempus TM and PAXgene® st
- Page 81 and 82: 165 Benchmarking miRNA ExpressionLe
- Page 83 and 84: Phoenix crystallography robot and a
- Page 85 and 86: Laboratory is located next door and
- Page 87 and 88: data of a Thermo Orbitrap instrumen
- Page 89 and 90: **197 Multi-Functional Superparamag
- Page 91 and 92: pattern of N-linked glycans in form
- Page 93 and 94: advantage of using two separate 15
- Page 95 and 96: allowed absolute quantitation. Comp
- Page 97 and 98: levels between the animal groups. A
- Page 99 and 100: MuDPIT, and off-gel electrophoresis
- Page 101 and 102: 237 Multi-Site Assessment of Proteo
- Page 103 and 104: with good limits of quantification
- Page 105 and 106: 249 Rapid Monoclonal Antibody Glyca
- Page 107 and 108: OOng, J. - 117PPatel, S. - 169Peake
- Page 109 and 110: AnaSpec, Eurogentec Group Booth 417
- Page 111 and 112: FASEB MARC Program Booth 4169650 Ro
- Page 113 and 114: IntegenX, Inc. Booth 2015720 Stoner
- Page 115 and 116: Nonlinear Dynamics Booth 1052530 Me
- Page 117 and 118: Roche Applied Science Booth 5009115
- Page 119 and 120: Exhibit Hall FloorplanGrand Oaks Ba
- Page 121: Exhibitor List in Booth OrderExhibi
- Page 125 and 126: Grand Oaks Ballroom,Rooms P&Q, Leve
- Page 127 and 128: NotesNotesABRF 2011 — Technologie
- Page 129 and 130: Tuesday, February 22 — 12:00 pm -
- Page 131 and 132: MARCH 16-20, 2012 • DISNEY’S CO